Systematic review and meta-analysis of pharmacological treatment of the symptoms of attention-deficit/hyperactivity disorder in children with pervasive developmental disorders

Journal of Autism and Developmental Disorders

Volumn 43, Issue 10, 2013, Pages 2435-2441

  Reichow, Brian ^a   Volkmar, Fred R ^a   Bloch, Michael H ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ADHD; ASD; Atomoxetine; Attention deficit hyperactivity disorder; Autism; Autism spectrum disorder; Clonidine; Meta analysis; Methylphenidate; PDD; PDD NOS; Pervasive developmental disorder

Indexed keywords

ATOMOXETINE; CLONIDINE; METHYLPHENIDATE; PLACEBO;

ATTENTION DEFICIT DISORDER; AUTISM; DRUG EFFICACY; HUMAN; META ANALYSIS; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; REVIEW; SYMPTOMATOLOGY; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; METHYLPHENIDATE; PROPYLAMINES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84884978490     PISSN: 01623257     EISSN: 15733432     Source Type: Journal    
DOI: 10.1007/s10803-013-1793-z     Document Type: Review

References (41)

1. Aman, M. G.; Arnold, L.; McDougle, C. J.; Vitiello, B.; Scahill, L.; Davies, M.; et al. (2005). Acute and long-term safety and tolerability of risperidone in children with autism. Journal of Child and Adolescent Psychopharmacology, 15(6), 869-884.
2. American Psychiatric Association. (2000). Diagnostic and statistical manual (4th ed.; text revision). Washington, DC: American Psychiatric Association.
3. Arnold, L. E.; Aman, M. G.; Cook, A. M.; Witwer, A. N.; Hall, K. L.; Thompson, S.; et al. (2006). Atomoxetine for hyperactivity in autism spectrum disorders: Placebo-controlled crossover pilot trial. Journal of the American Academy of Child and Adolescent Psychiatry, 45(10), 1196-1205.
4. Borenstein, M.; Hedges, L.; Higgins, J.; & Rothstein, H. (2005). Comprehensive meta-analysis 2. Englewood, NJ: Biostat.
5. Cheng, J. Y. W.; Chen, R. Y. L.; Ko, J. S. N.; & Ng, E. M. L. (2007). Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents - meta-analytsis and meta-regression analysis. Pyschopharmacology, 194(2), 197-209.
6. Conners, C. (2001). Conners' rating scales-revised: Technical manual. North Tonawanda, NY: Multi-Health Systems.
7. Connor, D.; Fletcher, K. E.; & Swanson, J. M. (1999). A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 38(12), 1551-1559.
8. DuPaul, G. J.; Anastopoulos, A. D.; Power, T. J.; Reid, R.; Ikeda, M. J.; & McGoey, K. E. (1998). Parent ratings of attention-deficit/hyperactivity disorder symptoms: factor structure and normative data. Journal of Psychopathologic Behavioral Assessment, 20, 83-102.
9. Faraone, S.; & Buitelaar, J. (2010). Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis. European Child and Adolescent Psychiatry, 19, 353-364.
10. Frazier, J. A.; Biederman, J.; Bellordre, C. A.; Garfield, S. B.; Geller, D. A.; Coffey, B. J.; et al. (2001). Should the diagnosis of attention-deficit/hyperactivity disorder be considered in children with pervasive developmental disorder? Journal of Attention Disorder, 4(4), 203-211.
11. Gargaro, B. A.; Rinehart, N. J.; Bradshaw, J. L.; Tonge, B. J.; & Sheppard, D. M. (2011). Autism and ADHD: How far have we come in the comorbidity debate? Neuroscience and Biobehavioral Review, 35, 1081-1088.
12. Ghuman, J. K.; Aman, M. G.; Lecavalier, L.; Riddle, M. A.; Gelenberg, A.; Wright, R.; et al. (2009). Randomized, placebo-controlled, cross-over study of methylphenidate for attention-deficit/hyperactivity disorder symptoms in preschoolers with developmental disorders. Journal of Child and Adolescent Psychopharmacology, 19(4), 329-339.
13. Grzadzinski, R.; Di Martino, A.; Brady, E.; Mairena, M. A.; O'Neale, M.; Petkova, E.; et al. (2011). Examining autistic traits in children with ADHD: Does the autism spectrum extend to ADHD? Journal of Autism and Developmental Disorders, 41(9), 1178-1191.
14. Handen, B. L.; Johnson, C. R.; & Lubetsky, M. (2000). Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder. Journal of Autism and Developmental Disorders, 30(3), 245-255.
15. Harfterkamp, M.; van de Loo-Neus, G.; Minderaa, R. B.; van der Gaag, R. J.; Escobar, R.; Schacht, A.; et al. (2012). A randomized double-blind study of atomoxetine versus placebo for attention-deficit/hyperactivity disorder symptoms in children with autism spectrum disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 51(7), 733-741.
16. Hazell, P. (2007). Drug therapy for attention-deficit/hyperactivity disorder-like symptoms in autistic disorder. Journal of Paediatrics and Child Health, 43(1-2), 19-24.
17. Hedges, L.; & Olkin, I. (1985). Statistical methods for meta-analysis. New York, NY: Academic Press.
18. Heudo-Medina, T.; Sanchez-Meca, J.; Marin-Marinez, F.; & Botella, J. (2006). Assessing heterogeneity in meta-analysis: Q statistic or I2 index. Psychological Methods, 11, 193-206.
19. Holtmann, M.; Bolte, S.; & Poustka, F. (2007). Attention deficit hyperactivity disorder symptoms in pervasive developmental disorders: Association with autistic behavior domains and coexisting psychopathology. Psychopathology, 40(3), 172-177.
20. Jaselskis, C. A.; Cook, E. H.; Jr.; Fletcher, K. E.; & Leventhal, B. L. (1992). Clonidine treatment of hyperactive and impulsive children with autistic disorder. Journal of Clinical Psychopharmacology, 12(5), 322-327.
21. Lecavalier, L. (2006). Behavioral and emotional problems in young people with pervasive developmental disorders: Relative prevalence, effects of subject characteristics, and empirical classification. Journal of Autism and Developmental Disorders, 36(8), 1101-1114.
22. Lee, D. O.; & Ousley, O. Y. (2006). Attention-deficit hyperactivity disorder symptoms in a clinic sample of children and adolescents with pervasive developmental disorders. Journal of Child & Adolescent Psychopharmacology, 16(6), 737-746.
23. Leyfer, O. T.; Folstein, S. E.; Bacalman, S.; Davis, N. O.; Dinh, E.; Morgan, J.; et al. (2006). Comorbid psychiatric disorders in children with autism: Interview development and rates of disorders. Journal of Autism and Developmental Disorders, 36(7), 849-861.
24. Mandell, D. S.; Morales, K. H.; Marcus, S. C.; Stahmer, A. C.; Doshi, J.; & Polsky, D. E. (2008). Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders. Pediatrics, 121(3), e441-e448.
25. McPheeters, M. L.; Warren, Z.; Sathe, N.; Bruzek, J. L.; Krishnaswami, S.; Jerome, R. N.; et al. (2011). A systematic review of medical treatments for children with autism spectrum disorders. Pediatrics, 127(5), e1312-e1321.
26. Moher, D.; Liberati, A.; Tetzlaff, J.; Altman, D. G.; & The PRISMA Group (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med, 6(7), e1000097.
27. MTA Group. (1999). A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Archieves of General Psychiatry, 56(12), 1073-1086.
28. Oswald, D. P.; & Sonenklar, N. A. (2007). Medication use among children with autism spectrum disorders. Journal of Child & Adolescent Psychopharmacology, 17(3), 348-355.
29. Quintana, H.; Birmaher, B.; Stedge, D.; Lennon, S.; Freed, J.; Bridge, J.; et al. (1995). Use of methylphenidate in the treatment of children with autistic disorder. Journal of Autism & Developmental Disords, 25(3), 283-294.
30. Research Units on Peadiatric Psychopharmolcology. (2005). Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Archieves of General Psychiatry, 62(11), 1266-1275.
31. Rosenberg, R.; Mandell, D. S.; Farmer, J. E.; Law, J. K.; Marvin, A. R.; & Law, P. A. (2010). Psychotropic medication use among children with autism spectrum disorders enrolled in a national registry, 2007-2008. Journal of Autism and Developmental Disorders, 40, 342-351.
32. Schachter, H.; Pham, B.; King, J.; Langford, S.; & Moher, D. (2001). How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. CMAJ, 2001(165), 11.
33. Simonoff, E.; Pickles, A.; Charman, T.; Chandler, S.; Loucas, T.; & Baird, G. (2008). Psychiatric disorders in children with autism spectrum disorders: Prevalence, comorbidity, and associated factors in a population-derived sample. Journal of the American Academy of Child and Adolescent Psychiatry, 47(8), 921-929.
34. Sinzig, J.; Walter, D.; & Doepfner, M. (2009). Attention deficit/hyperactivity disorder in children and adolescents with autism spectrum disorder: Symptom or syndrome? Journal of Attention Disorder, 13(2), 117-126.
35. Spencer, T.; Biederman, J.; Wilens, T.; Harding, M.; O'Donnell, D.; & Griffin, S. (1996). Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. Journal of the American Academy of Child and Adolescent Psychiatry, 35(4), 409-432.
36. Sterne, J. A. C.; Egger, M.; & Moher, D. (2008). Addressing reporting biases. In J. P. T. Higgins & S. Green (Eds.), Cochrane handbook for systematic reviews of interventions (pp. 297-333). Chichester, UK: Wiley.
37. Stigler, K. A.; Desmond, L. A.; Posey, D. J.; Wiegand, R. E.; & McDougle, C. J. (2004). A naturalistic retrospective analysis of psychostimulants in pervasive developmental disorders. Journal of Child & Adolescent Psychopharmacology, 14(1), 49-56.
38. Swanson, J.; Nolan, W, & Pelham, W. E. (1992). The SNAP-IV rating scale. Irvine, CA: University of California at Irvine.
39. van der Meer, J. M. J.; Oerlemans, A. M.; van Stijn, D. J.; Lappenschaar, M. G. A.; de Sonneville, L. M. J.; Buitelaar, J. K.; et al. (2012). Are autism spectrum disorder and attention-deficit/hyperactivity disorder different manifestations of one overarching disorder? Cognitive and symptom evidence from a clinical and population-based sample. Journal of the American Academy of Child and Adolescent Psychiatry, 51(11), 1160-1172.
40. Wilson, D. (2005). Meta-analysis macros for SPSS.
41. Yerys, B. D.; Wallace, G. L.; Sokoloff, J. L.; Shook, D. A.; James, J. D.; & Kenworthy, L. (2009). Attention deficit/hyperactivity disorder symptoms moderate cognition and behavior in children with autism spectrum disorders. Autism Research, 2(6), 322-333.